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Ethanol with the molecular formula C2H6O is a clear, colorless, volatile liquid 
with a pleasant smell made by fermentation of sugar. Ethanol is one of many kinds of 
alcohol and is the only type of alcohol that can be consumed. Apart from consump-
tion, ethanol is used for several other purposes such as fuel to power engines, as a 
disinfectant (because of its bactericidal activity), as a solvent and preservative as 
well as serving as the primary ingredient in the preparation of alcoholic beverages. 
In this chapter, the author describes how ethanol is metabolized in the body, genetics 
behind ethanol metabolism, metabolic pathways and hosts for ethanol production, 
ethanol and malnutrition, why ethanol is considered as a drug and effect of ethanol 
on neurotransmitter [gamma-amino-butyric acid (GABA), glutamate, dopamine, 
and serotonin] systems. The author further explains the effect of ethanol on antidi-
uretic hormone (vasopressin).
Keywords: ethanol, neurotransmitters, antidiuretic hormone, GABA, glutamate, 
dopamine, serotonin, metabolism
1. Introduction
Ethanol is a mood-altering drug with both pleasant and unpleasant effects. It 
is a clear liquid that is made by the fermentation of different biological materials. 
Ethanol (CH3CH2OH) is an alcohol, a group of chemical compounds whose mol-
ecules contain a hydroxyl group, –OH, bonded to a carbon atom [1]. When an alco-
holic beverage is consumed, it passes through the stomach into the small intestine 
where it is rapidly absorbed and distributed throughout the body. Alcohol cannot be 
stored in the body and therefore, the body must metabolize it to get rid of it. It can 
only be metabolized in the liver, where enzymes are found to initiate the process. 
Ethanol is metabolized in the body to provide energy and does not have any miner-
als, vitamins, carbohydrates, fats or protein associated with it and as a result of 
this, it directly contributes to malnutrition. General malnutrition is often reflected 
in body weight loss, mainly of adipose and muscle tissue. This loss of nutritional 
reserves is partly due to inadequate protein intake in the face of continued alcohol 
ingestion. Alcohol is very rich in energy, packing seven calories per gram. The more 
calories an individual consumes in alcohol, the less likely it is that the individual will 
eat enough food to obtain adequate nutrients. More ethanol is found in the blood 
and the brain than in muscle or fat tissue. Alcohol acts as a central nervous system 
(CNS) depressant and as a diuretic and affects several neurotransmitter systems 
within the brain such as glutamate, gamma-amino-butyric acid (GABA), dopamine 
and serotonin systems. Ethanol is also used as a fuel for internal combustion engines 
either alone or in combination with other fuels and has both short and long-term 
economic advantages over fossil fuel. One striking advantage of ethanol over other 
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fuel sources is that it does not cause pollution to the environment thereby reducing 
global warming which is caused by relentless emission of dangerous greenhouse 
gases emanation from use of fossil fuels.
2. Metabolism of alcohol
When an alcoholic beverage is consumed, it passes through the stomach into the 
small intestine where the ethanol is rapidly absorbed and distributed throughout 
the body and more ethanol is found in the blood and the brain than in muscle or 
fat tissue. Around 2–8% of consumed alcohol is lost through urine, sweat, or the 
breath and the other 92–98% is metabolized in the liver. Alcohol is metabolized 
by several pathways. These pathways involves four enzymes—alcohol dehy-
drogenase (ADH), aldehyde dehydrogenase (ALDH), catalase and microsomal 
ethanol oxidizing system (MEOS). These enzymes help break apart the alcohol 
molecule, making it possible to eliminate it from the body. In the first step, the 
primary pathway for alcohol metabolism involves alcohol dehydrogenase (ADH), 
a cytosolic enzyme that catalyzes the conversion of alcohol to acetaldehyde, a 
highly toxic substance and known carcinogen [2] (Figure 1). ADH is found mainly 
in the liver but can also be found in other organs of the body such as brain and 
stomach. During the process of conversion of ethanol to acetaldehyde, ethanol 
binds to alcohol dehydrogenase enzyme and loses some of its electrons in the form 
of hydrogen atoms to a coenzyme nicotinamide adenine dinucleotide (NAD) to 
form NADH. Ethanol oxidation generates an excess of reducing equivalents in the 
liver, mainly as NADH. NADH participates in numerous metabolic reactions in 
the body and for proper functioning of the body; the ratio of NAD to NADH must 
be tightly controlled. The conversion of ethanol to acetaldehyde by alcohol dehy-
drogenase enzyme reduces the cellular NAD to NADH ratio and this has profound 
effects on other liver metabolic pathways that require NAD or are inhibited by 
NADH. Decreased NAD/NADH ratio inhibits important reactions in the body such 
as glycolysis, tricarboxylic acid cycle (TCA cycle), fatty acid oxidation, pyruvate 
Figure 1. 
Metabolism of ethanol to acetic acid/acetate.
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dehydrogenase and gluconeogenesis. Altered NAD/NADH ratio/elevated cellular 
NADH levels may lead to several metabolic disorders. Elevated levels of NADH 
could lead to the formation of abnormally high levels of lactic acid, which in turn 
reduces the capacity of the kidney to excrete uric acid. Excessive uric acid in the 
body can lead to gout, a disorder characterized by extremely painful swelling of 
joints [3]. Increased NADH promotes the generation of the building blocks of fat 
molecules (fatty acids) and reduces the breakdown of fats in the liver, thereby 
contributing to fat accumulation in that organ [4]. The resulting fatty liver is the 
earliest stage and the most common form of alcohol-induced liver disease. The 
elevation in NADH levels resulting from the ADH-mediated breakdown of alcohol 
also may play a role in the formation of scar tissue that characterizes fibrosis, a 
more severe stage of liver disease.
Another pathway is the microsomal ethanol oxidizing system (MEOS). 
The primary component of the MEOS is the cytochrome P450, which exists 
in several variants. The variant most important for alcohol metabolism is 
cytochrome P450 2E1 (CYP2E1) [5]. This pathway uses NADPH as a coen-
zyme in the metabolism of ethanol and results in the formation of NADP 
and water (Figure 1). The cytochrome CYP2E1/MEOS pathway is only 
active after a person has consumed large amounts of alcohol [6]. Alcohol 
breakdown by microsomal ethanol oxidizing system generates several highly 
reactive  oxygen-containing molecules called reactive oxygen species (ROS). 
These reactive oxygen species can damage liver cells by inactivating essen-
tial enzymes and altering the breakdown of fat molecules and when there 
is an imbalance between ROS and antioxidant systems, a condition known 
as oxidative stress sets in which can cause liver cell damage. Alcohol and its 
metabolism have been shown to reduce the levels of both glutathione (GSH) 
and vitamin E (α-tocopherol) which protects the body against ROS [6]. The 
catalase pathway metabolizes only a small fraction of alcohol in the body [2].
In the second step, acetaldehyde is further metabolized down by aldehyde 
dehydrogenase (ALDH) to another less active by product called acetate (Figures 2  
and 3) which in turn is broken down into carbon dioxide and water. Ethanol is 
mainly eliminated from the body via metabolism into carbon dioxide and water. 
Acetate/acetic acid combine with Coenzyme A to form acetyl-CoA. The acetyl-CoA 
enters the  tricarboxylic acid (TCA) cycle/Krebs cycle. In the Krebs cycle, acetate 
in the form of acetyl CoA is broken down into carbon dioxide and in this process 
ATP is formed (Figure 3) [2]. Some individuals have less effective forms of ethanol 
metabolizing enzymes and can experience more marked symptoms from ethanol 
consumption than others [7].
Figure 2. 
Acetaldehyde dehydrogenases in ethanol and pyruvate metabolism.
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3. Genetics behind ethanol metabolism
Important factors that can influence responses to alcohol are variations in 
alcohol-metabolizing enzymes. Genetically influenced metabolic factors have been 
implicated in the etiology of alcoholism among different ethnic groups. Several 
genetically determined variants of ADH and ALDH enzymes exist that differ in 
their level of activity and different people have different variants of these enzymes. 
Some of these enzyme variants work more or less efficiently than others; this 
means that some people can break down ethanol to acetaldehyde, or acetaldehyde 
to acetate, more quickly than others. The type of ADH and ALDH an individual 
carries has been shown to influence how much he or she drinks, which in turn influ-
ences his or her risk for developing alcoholism [8].
Genetic differences in ADH and ALDH enzymes may help to explain why some 
ethnic groups have higher or lower rates of alcohol-related problems. There are 
multiple ADH and ALDH enzymes that are encoded by different genes. These genes 
occur in several variants and the enzymes encoded by these alleles can differ in the 
rate at which they metabolize ethanol or acetaldehyde or in the levels at which they 
are produced and these variants have been shown to influence a person’s drinking 
levels and consequently the risk of developing alcohol abuse or dependence [8]. 
Studies have shown that people carrying certain ADH and ALDH alleles are at 
significantly reduced risk of becoming alcohol dependent. The mechanism through 
which ADH and ALDH variants influence alcoholism risk is thorough the elevation 
of acetaldehyde levels, resulting either from a more rapid ethanol oxidation or from 
slower acetaldehyde oxidation. Acetaldehyde is a toxic substance whose accumula-
tion leads to a highly aversive reaction.
Humans have seven different ADH genes called ADH1A, ADH1B, ADH1C, 
ADH4, ADH5, ADH6, and ADH7 and there are three different ADH1B alleles: the 
ADH1B*1 allele, ADH1B*2 (this allele is common in Asians) and the ADH1B*3 
(this allele primarily is found in people of African descent) alleles. The ADH1B*2 
allele is associated with rapid ethanol oxidation and has shown protective effects 
against alcohol dependence in a variety of populations and ethnic groups. ADH1B*2 
allele is found at high frequency in East Asians and it has been shown to be protec-
tive against alcoholism [8, 9]. ADH1B*2 allele is not very common in European or 
Figure 3. 
Metabolism of ethanol to acetyl CoA. Numbered reactions are catalyzed by the following enzymes: 1: 
mitochondrial pyruvate carrier; 2: pyruvate dehydrogenase complex; 3: pyruvate decarboxylase; 4: acetaldehyde 
dehydrogenase; 5: acetyl-CoA synthetase; 6: carnitine shuttle; 7: alcohol dehydrogenase; 8: pyruvate carboxylase.
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African populations but also provides protection against alcoholism [10]. ADH1B*2 
allele is found at moderate frequencies among people of Jewish descent and reduces 
binge drinking and risk for alcoholism [11, 12]. The protective effect of ADH1B*2 
appears to be weaker in European than in Asian populations [10]. This differ-
ence could result from different social and environmental factors. The ADH1B*3 
allele had a significant protective effect on risk for alcoholism in a set of African-
American families selected for having multiple alcoholic members [13].
Numerous polymorphisms exist in the human ALDH genes, some of which 
cause inborn errors of metabolism and contribute to clinically relevant diseases 
[14]. Several isozymes of ALDH have been identified, but only the cytosolic ALDH1 
and the mitochondrial ALDH2 metabolize acetaldehyde produced during ethanol 
oxidation [8, 15]. Polymorphism in the ALDH2 gene is associated with altered 
acetaldehyde metabolism, alcohol-induced ‘flushing’ syndrome, decreased risk for 
alcoholism and increased risk of ethanol-induced cancers. Genetic polymorphism 
of the ALDH2 gene result in allelic variants ALDH2*1 and ALDH2*2. ALDH2*2 
allele is relatively common in people of Chinese, Japanese, and Korean descent but 
is essentially absent in people of European or African descent [8, 16]. People car-
rying an ALDH2*2 allele show an alcohol flush reaction, even when they consume 
only relatively small amounts of alcohol [17]. In these people, acetaldehyde levels in 
the blood increase from nearly undetectable levels to levels high enough to trigger 
the highly aversive reactions.
4. Metabolic pathways and hosts for ethanol production
Ethanol is produced from glucose via fermentative consumption of pyruvate, the 
end product of glycolysis [18]. Glycolysis is a metabolic process that converts glu-
cose to pyruvate while producing ATP. The pyruvate formed by glycolysis is further 
metabolized via one of the three catabolic routes. In aerobic organisms or tissues, 
under aerobic conditions, pyruvate is oxidized with the loss of its carboxyl group as 
CO2 to yield the acetyl-CoA; the acetyl-CoA is then completely oxidized to CO2 in 
the citric acid cycle (Figure 4). The second route for pyruvate is its reduction to lac-
tate via lactic acid fermentation in vigorously contracting muscle. Under anaerobic 
condition, pyruvate is reduced to lactate. Another major route of pyruvate catabo-
lism leads to ethanol. In some plant tissues and certain invertebrates, protists and 
microorganisms such as brewer’s yeast, pyruvate under anaerobic conditions can be 
fermented to ethanol by sequential reactions of pyruvate decarboxylase (PDC) and 
alcohol dehydrogenase (ADH) (Figure 4).
Microbial fermentation was introduced by Louis Pasteur in the late 1850s and 
was the first to recognize the relationship between the presence of yeast cells and 
the conversion of sugar to ethanol. Today ethanol producing Saccharomyces cerevisiae 
(yeast) have been exploited to produce a wide variety of alcoholic beverages and 
biofuels. Many microorganisms are being used for ethanol and biofuel production, 
but all have certain limitations such as industrial robustness, substrate utilization, 
productivity and yield. Saccharomyces cerevisiae (yeast) is a leading traditional 
industrial biocatalyst microorganism for ethanol production and with technological 
advancement in genetic engineering, bacteria such as Escherichia coli, Zymomonas 
mobilis, Corynebacterium glutamicum and Bacillus subtilis have been developed [19].
Zymomonas mobilis (Z. mobilis), a bacterium commonly found in plant saps and 
in honey has many desirable industrial biocatalyst characteristics and has been sug-
gested as an alternative to the classical model, Saccharomyces cerevisiae (yeast) due to 
its advantage for ethanol yield. Saccharomyces cerevisiae uses the Embden-Meyerhof-
Parnas (EMP) pathway for glycolysis while Z. mobilis uses the Entner-Doudoroff 
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(ED) pathway. The ED pathway is found in strict aerobic microorganisms and 
conducts fermentation with 50% less ATP produced relative to the EMP pathway, 
which leads to improved ethanol yield. Moreover, Z. mobilis has a high-specific 
cell surface area and consumes glucose faster than S. cerevisiae, leading to higher 
ethanol productivity than S. cerevisiae [20] (Figure 5). Although the EMP pathway 
is a major glycolytic route in most eukaryotes and prokaryotes, glycolytic pathways 
are much more diverse in prokaryotes [21]. Among different glycolytic pathways, 
the ED and EMP pathways are the most abundant pathway for glycolysis [21]. Two 
molecules of ATP are produced from each molecule of glucose consumed using 
EMP pathway, while the ED pathway produces only one ATP molecule from one 
glucose molecule. Given that ATP is tightly coupled with anabolism and cell growth, 
ED pathway-utilizing Z. mobilis produces less energy than EMP pathway-dependent 
species such as S. cerevisiae and consequently, Z. mobilis has more available carbons 
for ethanol fermentation with 2.5-fold higher specific ethanol productivity than 
that of S. cerevisiae [22].
Z. mobilis is an obligately fermentative bacterium which lacks a functional 
system for oxidative phosphorylation. Like the Saccharomyces cerevisiae, Z. mobilis 
produces ethanol and carbon dioxide as principal fermentation products. Ethanol is 
produced by Z. mobilis using a short pathway which requires two enzymatic activi-
ties: pyruvate decarboxylase and alcohol dehydrogenase. Pyruvate decarboxylase 
is the key enzyme in this pathway which diverts the flow of pyruvate to ethanol. 
In this pathway, the non-oxidative decarboxylation of pyruvate to produce acetal-
dehyde and carbon dioxide is catalyzed by pyruvate decarboxylase. In Z. mobilis, 
two alcohol dehydrogenase isozymes are present which catalyzes the reduction of 
acetaldehyde to ethanol during fermentation.
Figure 4. 




5. Ethanol and malnutrition
Ethanol consumption has an effect on person’s nutritional status. Many people 
who consume one to two glasses or less of alcoholic beverages per day consider 
those beverages a part of their normal diet and acquire a certain number of calories 
from them. When consumed in excess, ethanol can interfere with the nutritional 
status of the consumer. Ethanol can alter the intake, absorption and utilization 
of various nutrients [23, 24]. The primary constituents of alcoholic beverages are 
water, ethanol (alcohol), sugars (carbohydrates) and negligible amounts of other 
nutrients like proteins, vitamins and minerals. Because alcoholic beverages provide 
almost no nutrients, they are considered as “empty calories”. Any calories provided 
by alcoholic beverages are derived from the carbohydrates and alcohol they contain. 
Ethanol has a caloric value of 7.1 kcal/g.
Figure 5. 
Ethanol fermentation pathways in S. cerevisiae and Z. mobilis (solid line: EMP glycolysis pathway; dashed 
line: ED glycolysis pathway). KDPG: 2-keto-3-deoxy-6-phosphogluconate; G6P: glucose 6-phosphate; 
F6P: fructose 6-phosphate; FBP: fructose 1,6-bisphosphate; DHAP: dihydroxyacetone phosphate; 
G3P: glyceraldehyde 3-phosphate.
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Many consumers of alcoholic beverages suffer from various degrees of mal-
nutrition (both primary and secondary malnutrition). A situation where alcohol 
replaces other nutrients in the diet resulting in overall reduced nutrient intake is 
known as primary malnutrition while secondary malnutrition occurs when alco-
holics consumes adequate nutrients but alcohol interferes with the absorption of 
those nutrients from the intestine so they are not available to the body [25]. The 
risk of developing micro- and macronutrient deficiencies increases significantly 
when alcohol makes up more than 30% of total caloric intake [26]. Heavy alcohol 
consumption not only influences the drinker’s diet but also affects the metabolism 
of those nutrients that are consumed. Even if the drinker ingests sufficient proteins, 
fats, vitamins, and minerals, deficiencies may develop if those nutrients are not 
adequately absorbed from the gastrointestinal tract into the blood, are not broken 
down properly, and/or are not used effectively by the body’s cells.
Proteins are essential nutrients for the human body that help maintain the cell’s 
structure, act as enzymes that mediate almost all biochemical processes/reactions 
occurring in the body and transport certain substances in the body. Amino acids are 
building blocks of proteins and proteins are composed of 20 different amino acids. 
Some of these amino acids can be made by the body itself (non-essential amino 
acids) from various precursors or are recycled when proteins that are damaged or 
are no longer needed are broken down or degraded. Other amino acids cannot be 
produced by the body and must be obtained through diet (essential amino acids). 
Heavy alcohol consumption can interfere with the production and uptake of these 
non-essential and essential amino acids. Vitamins are micronutrients present in 
food essential for normal metabolism and insufficient levels of vitamin in the 
body can lead to serious health consequences. Alcoholics tends to have deficiencies 
in certain vitamins particularly thiamine (vitamin B1), riboflavin (vitamin B2), 
pyridoxine (vitamin B6), ascorbic acid (vitamin C) and folic acid.
6. Ethanol as a psychoactive drug and its effect on neurotransmitters
Ethanol is a psychoactive substance which is present as the active ingredient in 
alcoholic beverages such as beer, wine, and distilled spirits [27]. Ethanol consump-
tion produces mood lift and euphoria, decreased anxiety, increased sociability, 
sedation, impairment of cognitive, memory, motor, and sensory function, and 
slows down the activity (depressant) of the central nervous system (CNS) and 
because of its psychoactive effects, it is considered a drug. Psychoactive substances 
are those substances that act on the nervous system to alter states of conscious-
ness, modify perceptions and change moods. Psychoactive drugs are classified into 
depressants, stimulants and hallucinogens. Depressants slow down physical and 
mental activity; Stimulants increases the activity of the central nervous system 
while Hallucinogens modify perceptions and produce unusual visual images.
Human behaviors and emotions are modulated by neurotransmitters that act as 
keys between neurons. Ethanol has been shown to affect a variety of neurotransmit-
ters in the CNS. A neurotransmitter is a chemical that helps transmit messages from 
cell to cell within the nervous system and are crucial to muscle control, influences 
thought processes, memory and emotion. Alcohol mainly affects the nerve cells in 
the brain, causing interference between communication of these cells and other 
cells throughout the body. This interference restrains the activities of the excitatory 
nerve pathways and increases the activities of inhibitory nerve pathways. Alcohol 
affects several neurotransmitter systems—those for GABA, glutamate, serotonin and 
dopamine. Alcohol is an agonist for GABA, serotonin and dopamine—it increases 
their activity and is an antagonist for glutamate—it reduces glutamate activity.
9Ethanol
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Neurotransmitters interact with receptors on the dendrites of the other neuron 
and have specific shapes that fit into a receptor that can accommodate that shape. 
Once the neurotransmitter and the receptor are connected, the neurotransmitter 
sends information to the next neuron to either fire an action potential, or to inhibit 
firing (Figure 6). Neurotransmitters can either be excitatory or inhibitory accord-
ing to the effect they have on the second neuron once they are released into the 
synaptic gap. Excitatory neurotransmitter triggers depolarization, increasing the 
likelihood of a response while inhibitory neurotransmitter triggers hyperpolariza-
tion, decreasing the likelihood of a response. Excitatory and inhibitory synaptic 
transmission use different neurotransmitters and receptors. Excitatory synaptic 
transmission uses a neurotransmitter called glutamate. Glutamate is a common 
amino acid used in the body to build proteins. In the central nervous system, it is 
the major excitatory neurotransmitter where it interacts with glutamate receptors 
in the post-synaptic neuron. These receptors are ion channels that are permeable 
to sodium ions (Na+) and thus generate an action potential. Excitatory synaptic 
transmission also uses other neurotransmitter like acetylcholine, nitric oxide and 
catecholamines (norepinephrine, epinephrine and dopamine).
Inhibitory synaptic transmission uses a neurotransmitter called gamma-amino 
butyric acid (GABA). This interacts with GABA receptors, ion channels that are 
permeable to negatively charged chloride ions and opening of these channels 
makes it harder for a neuron to generate an action potential. Inhibitory synaptic 
transmission also uses serotonin, glycine and taurine as neurotransmitter. The main 
inhibitory neurotransmitter in the brain is GABA [28] and two major subtypes of 
GABA receptor have been described. The GABAA receptor family of ligand-gated 
ion channels consists of pentameric complexes containing binding sites for GABA 
agonists and other agent. The GABAA receptor complex regulates chloride ion flux 
through a coupled chloride channel and ethanol is widely reported to increase the 
activation of GABAA receptors.
Ethanol is an indirect GABA agonist and psychotropic depressant of the CNS 
[29]. This property is associated with the action of alcohol on different neurotrans-
mitters, including the stimulation of gamma-amino butyric acid and the inhibition 
of glutamate, the main central excitatory neurotransmitter. Alcohol potentiates the 
effects of GABA by acting directly on its receptors, enhancing their inhibitory effect 
which includes sedation, loss of inhibitions and relaxation [30]. The mechanism 
Figure 6. 
Neuron-neuron interaction—transmission of impulse across the synapse.
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by which ethanol enhances GABAA inhibitory currents involved a hyperpolar-
izing shift in the GABAA inhibitory postsynaptic current (IPSC) reversal potential 
in cortex neurons and increasing the amplitude of GABAA receptor-mediated 
conductance in septal neurons [31]. When GABAA receptor activation is enhanced 
by ethanol, it may involve enhancement of the initial peak of Cl− current through 
the channel rather than the sustained component of channel opening [32]. The 
enhancement of the GABAA receptor activation by ethanol may be modulated, in 
part, by protein kinase C (PKC) [33].
Glutamate is a major excitatory neurotransmitter in the brain that exerts its 
effects through several receptor subtypes, including the N-methyl-D-aspartate 
(NMDA) receptor. Unlike the case with GABA, alcohol inhibits glutamate activity 
in the brain. In a region of the brain called striatum which contains the nucleus 
accumbens, ethanol exposure causes a drop in the extra cellular glutamate levels 
[34]. Following acute administration ethanol, glutamate mediated signal transmis-
sion is suppressed in the central nucleus of the amygdala and this effect is enhanced 
following chronic alcohol exposure [35]. Ethanol inhibits ionotropic glutamate, 
amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and kainate 
receptors activity in the brain and N-methyl-D-aspartate (NMDA) receptors are the 
major target of ethanol’s inhibitory action. Ethanol also inhibits the induction of 
neural plasticity in many brain regions including the dorsal and ventral striatum as 
a result of inhibitory effects on ionotropic receptors, especially the NMDA receptors 
[36, 37].
Serotonin is a monoamine neurotransmitter known as 5-HT, a derivative of 
tryptophan and is extensively found in the gastrointestinal tract, platelets and the 
CNS. Serotonin plays a role in many brain processes, including regulation of body 
temperature, sleep, mood, appetite, pain and modulates behavioral response to 
unfairness [38]. Defect with the serotonin pathway can cause obsessive-compulsive 
disorder, anxiety disorders and depression. Most of the drugs used to treat depres-
sion today work by increasing serotonin levels in the brain [39]. Alcohol increases 
serotonin release in the nervous system. Increase in concentrations of serotonin 
in the urine and blood have been observed after taking alcohol. Alcohol exposure 
alters various aspects of serotonin’s synaptic functions and also interferes with the 
function of serotonin receptors including the 5-HT1A, 5-HT1B, 5-HT2, and 5-HT3 
receptors. Each subtype of serotonin receptors has its own specific influence on 
behavior related to the consumption of alcohol [40]. 5-HT1A may control consum-
matory behavior, including alcohol consumption while 5-HT1B may contribute not 
only to alcohol’s intoxicating effects, but also influence the development of toler-
ance to alcohol. 5-HT2 plays a role in alcohol’s rewarding effects and contributes 
to the development of alcohol withdrawal symptoms while 5-HT3 has a part in 
regulating alcohol consumption. Serotonin also affects other neurotransmitters. For 
example, alcohol-facilitated serotonin may affect the GABA system [41]. Similarly, 
alcohol-influenced serotonin works to stimulate increased dopamine production 
and, thus, increased emotional behavior [42].
Dopamine is a neurotransmitter primarily involved in a circuit called the meso-
limbic system, which projects from the brain’s ventral tegmental area to the nucleus 
accumbens. It is an excitatory neurotransmitter in the catecholamine family respon-
sible for modulating reward and pleasure. It plays a key role in regulating emotional 
responses, the reward seeking processes and movement. Several lines of evidence 
converge to demonstrate that the dopaminergic mesolimbic system plays a signifi-
cant part in the motivational and reinforcement mechanisms related to behaviors 
that are vital to survival [43]. Alcohol increases dopaminergic transmission in the 
mesolimbic pathway and increases the firing rate of dopaminergic neurons, which 




7. Effect of ethanol on antidiuretic hormone (vasopressin)
Vasopressin is an antidiuretic hormone that plays a major role in the regulation 
of water excretion. The posterior pituitary gland releases vasopressin in response 
to a fall in blood volume or a rise in plasma osmolality and acts to conserve water 
by increasing the permeability of water to the distal convoluted tubules and col-
lecting tubules in the renal nephrons through insertion of aquaporin-2 channels 
into the apical membrane of the tubular epithelial cells [44]. Ingestion of alcohol 
does increase plasma osmolality, but alcohol also acts directly to inhibit the release 
of vasopressin, independent of plasma osmolality. Once ethanol is consumed, it is 
distributed in the blood, brain and muscle tissues. Alcohol is a diuretic that affects 
five centers in the brain namely the cerebral cortex, limbic system, cerebellum, 
hypothalamus and pituitary gland and the medulla. The hypothalamus controls 
the automatic functions of the brain and coordinates endocrine functions through 
nerve impulse actions on the pituitary gland. Ethanol affects hypothalamus and 
pituitary gland by increasing urine excretion; inhibiting the pituitary secretion of 
anti-diuretic hormone (ADH), which makes the kidney reabsorb water. When the 
ADH levels are decreased, the kidney does not reabsorb water from the urine which 
results in the kidney producing more urine.
8. Conclusion
In conclusion, ethanol is a powerful drug that affects several neurological 
pathways such as the dopaminergic, serotoninergic, γ-amino butyric acid (GABA) 
and glutamate pathways and causes significant changes in the brain. It also affects 
the central nervous system and acts to depress brain functions, very much in the 
style of an anesthetic. Ethanol at low blood concentrations releases behaviors that 
are otherwise inhibited and usually produces feelings of relaxation and good mood 
which may facilitate socializing. Thus at low doses, ethanol is possibly useful but 
caution however needs to be exercised as even low quantities of alcohol affect the 
ability of the brain (hippocampus) to process information, which in turn impairs 
memory formation. Higher doses of alcohol affect the brain further by inducing 
intoxication wherein the person may experience temporary loss of coordination and 
judgment. Long-term alcohol abuse produces physiological changes in the brain and 
these changes in the brain chemistry maintain the alcoholic’s compulsive inability 
to cease alcohol consumption being fully aware of the harm caused by alcohol and 
results in alcohol withdrawal syndrome upon discontinuation of alcohol.
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